This study examined whether giving antifungal medications to peritoneal dialysis patients with infections could prevent fungal peritonitis. The researchers found that patients receiving antifungal prophylaxis actually had higher rates of secondary fungal infections compared to those without it. Additionally, fluconazole treatment was associated with dangerous changes in heart electrical activity, suggesting potential cardiac risks.